COMMISSION DELEGATED REGULATION (EU) 2020/689
of 17 December 2019
supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases
(Text with EEA relevance)
PART I
GENERAL PROVISIONS
Article 1
Subject-matter and scope
Article 2
Definitions
PART II
SURVEILLANCE, ERADICATION PROGRAMMES, DISEASE-FREE STATUS
CHAPTER 1
Surveillance
Section 1
Design of surveillance, Targeted animal population and diagnostic methods
Article 3
Design of surveillance
Article 4
Targeted animal population
Article 5
Exclusion of certain kept terrestrial animals from the targeted animal population
Article 6
Diagnostic methods
Article 7
Contribution of official controls and other official activities to animal health surveillance
Section 2
Disease confirmation and case definitions
Article 8
Criteria for official confirmation of listed diseases, other than category A diseases, and certain emerging diseases and subsequent confirmation of outbreaks
Article 9
Case definitions
Section 3
Union surveillance programme
Article 10
Criteria for and contents of Union surveillance programmes
Article 11
Information to be included in the submission of and reporting on Union surveillance programmes
CHAPTER 2
Eradication programmes for category B and C diseases of terrestrial animals
Section 1
General provisions
Article 12
Disease control strategy for the eradication of category B and C diseases of terrestrial animals
Article 13
Territorial scope and animal populations
Article 14
Final and intermediate targets
Article 15
Period of application
Section 2
Requirements for eradication programmes based on granting disease-free status at the level of establishments
Article 16
Disease control strategy based on the disease-free status at establishment level
Article 17
Targeted and additional animal populations for eradication programmes for certain diseases
Article 18
Obligations of operators with respect to eradication programmes for certain diseases
Article 19
Derogation with regard to granting disease-free status to establishments
Article 20
Obligation of the competent authority to grant, suspend and withdraw disease-free status
Article 21
Disease control measures in the event of suspicion of certain diseases
Article 22
Extension of disease control measures in the event of suspicion of certain diseases
Article 23
Derogations from disease control measures in the event of suspicion of certain diseases
Article 24
Official confirmation of certain diseases and disease control measures
Article 25
Epidemiological enquiry and investigations in case of confirmation of certain diseases
Article 26
Movement of animals to or from infected establishments
Article 27
Testing and removal of animals from infected establishments
Article 28
Management of products from infected establishments
Article 29
Derogations from the restriction of movement of animals from infected establishments
Article 30
Cleaning and disinfection and other measures to prevent the spread of infection
Article 31
Risk mitigating measures to prevent reinfection
Section 3
Provisions for eradication programmes for infection with RABV
Article 32
Disease control strategy of eradication programmes for infection with RABV
Article 33
Targeted animal population for eradication programmes for infection with RABV
Article 34
Obligations of the competent authority in the context of eradication programmes for infection with RABV
Article 35
Disease control measures in the event of suspicion of infection with RABV
Article 36
Disease control measures in the event of confirmation of infection with RABV
Section 4
Provisions for eradication programmes for infection with BTV
Article 37
Disease control strategy of eradication programmes for infection with BTV
Article 38
Targeted and additional animal populations for eradication programmes for infection with BTV
Article 39
Obligations of operators in the context of eradication programmes for infection with BTV
Article 40
Obligations of the competent authority in the context of eradication programmes for infection with BTV
Article 41
Disease control measures in the event of suspicion of infection with BTV
Article 42
Disease control measures in the event of confirmation of infection with BTV
Article 43
Movement of kept animals and germinal products from the targeted animal population to Member States or zones covered by eradication programmes for infection with BTV
Article 44
Vector protected establishment
Article 45
Movement of animals through Member States or zones covered by eradication programmes for infection with BTV
CHAPTER 3
Eradication programmes for category B and C diseases of aquatic animals
Section 1
General provisions
Article 46
Disease control strategy for the eradication of category B and C diseases of aquatic animals
Article 47
Territorial scope and animal population
Article 48
Final and intermediate targets
Article 49
Period of application
Section 2
Requirements for Eradication programmes
Article 50
Minimum requirements for an eradication programme
Article 51
Animal population to be included in eradication programmes for category B and C diseases
Article 52
Measures to be taken in Member States, zones or compartments covered by eradication programmes
Article 53
Derogation from classification of the health status of confined establishments
Article 54
Vaccination
Article 55
Disease control measures in the event of suspicion of certain diseases
Article 56
Extension of disease control measures in the event of suspicion of certain diseases
Article 57
Derogation from disease control measures in the event of suspicion of disease
Article 58
Official confirmation of certain diseases and disease control measures
Article 59
Epidemiological enquiry and investigations in case of confirmation of certain diseases
Article 60
Movements to or from an infected establishment and any other establishment located in the restricted zone
Article 61
Derogations from the restriction of movement of animals and products of animal origin from infected establishments
Article 62
Removal of infected animals
Article 63
Cleaning and disinfection
Article 64
Fallowing
Article 65
Risk mitigating measures to prevent reinfection
CHAPTER 4
Disease-free status
Section 1
Approval of disease-free status of Member States and zones
Article 66
Criteria for the granting of disease-free status
Article 67
Disease-free status based on the absence of listed species
Article 68
Disease-free status based on the disease agent’s incapacity to survive
Article 69
Disease-free status of terrestrial animals based on the incapacity to survive of listed vectors for listed diseases of terrestrial animals
Article 70
Disease-free status based on historical and surveillance data
Article 71
Disease-free status based on eradication programmes
Article 72
Disease specific requirements for disease-free status
Section 2
Approval of disease-free status for compartments keeping aquaculture animals
Article 73
Criteria for the granting of disease-free status to compartments keeping aquaculture animals
Article 74
Disease-free status based on the absence of listed species
Article 75
Disease-free status based on the disease agent’s incapacity to survive
Article 76
Disease-free status based on historical and surveillance data
Article 77
Disease-free status based on eradication programmes
Article 78
Disease specific requirements for disease-free status
Article 79
Specific requirements for compartments which are independent of the health status of the surrounding natural waters
Article 80
Special provisions for compartments which comprise individual establishments which commence or recommence aquaculture activities and where the health status regarding a specific disease is independent of the health status of the surrounding natural waters
Section 3
Maintenance, suspension and withdrawal of disease-free status
Article 81
Specific criteria on surveillance and biosecurity measures for the maintenance of disease-free status
Article 82
Suspension, withdrawal and restoration of disease-free status
Section 4
Derogations from approval by the Commission
Article 83
Derogations from approval by the Commission for certain disease-free statuses for aquatic animal diseases
PART III
TRANSITIONAL AND FINAL PROVISIONS
Article 84
Transitional provisions concerning existing disease-free status
Article 85
Transitional provisions concerning existing eradication or surveillance programmes
Article 86
Repeal
Article 87
Entry into force and application
ANNEX I
SPECIFIC CASE DEFINITION OF DISEASE OF TERRESTRIAL ANIMALS
Section 1
Highly pathogenic avian influenza (HPAI)
Section 2
Infection with low pathogenic avian influenza viruses (LPAIV)
Section 3
Infection with Newcastle disease virus (NDV)
ANNEX II
UNION SURVEILLANCE PROGRAMME
PART I
AVIAN INFLUENZA SURVEILLANCE IN POULTRY AND WILD BIRDS
Section 1
General approach and requirements
1. TERRITORIAL SCOPE
2. PERIOD OF APPLICATION
3. GENERAL APPROACH
Section 2
Objectives for surveillance in poultry and wild birds
Section 3
Early detection of HPAI in poultry
Section 4
Early detection of HPAI in wild birds
Section 5
Risk-based complementary surveillance for HPAI in poultry species which generally do not show significant clinical signs
Section 6
risk-based surveillance in order to identify clusters of establishments infected with lpaiv and with continuous spread of LPAIV
Section 7
Targeted poultry populations
Section 8
Targeted Wild bird populations
Section 9
Sampling and laboratory testing methods
ANNEX III
DIAGNOSTIC METHODS FOR THE GRANTING AND MAINTENANCE OF DISEASE-FREE STATUS FOR CERTAIN DISEASES OF TERRESTRIAL ANIMALS
Section 1
Infection with
Brucella abortus, B. melitensis
and
B. suis
Section 2
Infection with mycobacterium tuberculosis complex
Section 3
Enzootic bovine leukosis
Section 4
Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)
|
Methods: |
Matrix: |
non-vaccinated bovine animals |
BoHV-1 I-ELISA(1) |
individual serum samples(4) |
milk samples |
||
gB B-ELISA(2) |
individual serum samples(4) |
|
individual meat juice samples |
||
DIVA vaccinated bovine animals with a gE-deleted vaccine |
gE B-ELISA(3) |
individual serum samples |
individual meat juice samples |
Section 5
Infection with Aujeszky’s disease virus (ADV)
|
Methods: |
Matrix: |
non-vaccinated porcine animals |
ADV ELISA(5) |
individual or up to 5 pooled serum (or plasma) samples |
individual or up to 5 pooled filter paper samples |
||
individual meat juice samples |
||
DIVA vaccinated porcine animals with a gE-deleted vaccine |
gE ELISA(6) |
individual serum samples |
Section 6
Bovine viral diarrhoea (BVD)
ANNEX IV
DISEASE-SPECIFIC REQUIREMENTS FOR THE GRANTING, MAINTENANCE, SUSPENSION AND WITHDRAWAL OF THE DISEASE-FREE STATUS AT THE LEVEL OF ESTABLISHMENTS AND DISEASE-SPECIFIC REQUIREMENTS FOR THE GRANTING AND MAINTENANCE OF THE DISEASE-FREE STATUS AT THE LEVEL OF MEMBER STATES OR ZONES
PART I
INFECTION WITH
BRUCELLA ABORTUS, B. MELITENSIS
AND
B. SUIS
CHAPTER 1
Establishment free from infection with
Brucella abortus
,
B. melitensis
and
B. suis
without vaccination
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Establishment free from infection with
Brucella abortus
,
B. melitensis
and
B. suis
with vaccination
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 3
Member State or zone free from infection with
Brucella abortus
,
B. melitensis
and
B. suis
as regards kept bovine animals
Section 1
Granting of the status as regards kept bovine animals
Section 2
Maintenance of the status as regards kept bovine animals
CHAPTER 4
Member State or zone free from infection with
Brucella abortus
,
B. melitensis
and
B. suis
as regards kept ovine and caprine animals
Section 1
Granting of the status as regards kept ovine and caprine animals
Section 2
Maintenance of the status as regards kept ovine and caprine animals
PART II
INFECTION WITH
MYCOBACTERIUM TUBERCULOSIS
COMPLEX
CHAPTER 1
Establishment free from infection with
Mycobacterium tuberculosis
complex
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Member State or zone free from infection with MTBC
Section 1
Granting of the status as regards kept bovine animals
Section 2
Maintenance of the status
PART III
ENZOOTIC BOVINE LEUKOSIS
CHAPTER 1
Establishment free from enzootic bovine leukosis
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Member State or zone free from EBL
Section 1
Granting of the status
Section 2
Maintenance of the status
PART IV
INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS
CHAPTER 1
Establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Member State or zone free from IBR/IPV
Section 1
Granting of the status
Section 2
Maintenance of the status
PART V
INFECTION WITH AUJESZKY’S DISEASE VIRUS
CHAPTER 1
Establishment free from infection with Aujeszky’s disease virus
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Member State or zone free from infection with Aujeszky’s disease virus
Section 1
Granting of the status
Section 2
Maintenance of the status
PART VI
BOVINE VIRAL DIARRHOEA
CHAPTER 1
Establishment free from bovine viral diarrhoea
Section 1
Granting of the status
Section 2
Maintenance of the status
Section 3
Suspension and restoring of the status
Section 4
Withdrawal and regaining of the status
CHAPTER 2
Member State or zone free from bovine viral diarrhoea
Section 1
Granting of the status
Section 2
Maintenance of the status
ANNEX V
DISEASE SPECIFIC REQUIREMENTS FOR THE GRANTING AND MAINTENANCE OF THE DISEASE-FREE STATUS AT THE LEVEL OF MEMBER STATES OR ZONES
PART I
INFECTION WITH RABIES VIRUS
CHAPTER 1
Technical requirements for the vaccination against rabies
Section 1
Vaccination of kept animals
Section 2
Vaccination of wild animals
CHAPTER 2
Member State or zone free from infection with rabies virus
Section 1
Granting of the status
Section 2
Maintenance of the status
PART II
INFECTION WITH BLUETONGUE VIRUS (SEROTYPES 1-24)
CHAPTER 1
Minimum requirements for the surveillance
Section 1
Surveillance for the detection of serotypes of Bluetongue virus not reported in the previous 2 years
Section 2
Surveillance to determine the extent of infection with BTV
Section 3
Surveillance to demonstrate absence of infection with BTV
Section 4
Requirements for the active surveillance of infection with BTV
Section 5
Entomological surveillance
CHAPTER 2
Movement of animals and germinal products
Section 1
Movement of animals
Section 2
Movement of germinal products
CHAPTER 3
Vector protected establishment
CHAPTER 4
Member State or zone free from infection with BTV
Section 1
Granting of the status
Section 2
Maintenance of the status
CHAPTER 5
Seasonally BTV-free Member State or zone
PART III
INFESTATION WITH
VARROA
SPP.
Section 1
Granting of the status to a Member State or zone as free from infestation with
varroa
spp.
Section 2
Maintenance of the status of a Member State or zone free from infestation with
varroa
spp.
PART IV
STATUS FREE FROM INFECTION WITH NEWCASTLE DISEASE VIRUS- WITHOUT VACCINATION
Section 1
Granting of status free from infection with Newcastle disease virus without vaccination
Section 2
Maintenance of the status
ANNEX VI
SPECIFIC REQUIREMENTS AS REGARDS DISEASES OF AQUATIC ANIMALS
PART I
RISK-BASED SURVEILLANCE
CHAPTER 1
Minimum requirements for risk-based surveillance in certain approved aquaculture establishments
1.
General approach
CHAPTER 2
Risk ranking to be applied in certain approved aquaculture establishments
CHAPTER 3
Frequency of risk-based animal health visits
PART II
DISEASE- SPECIFIC REQUIREMENTS FOR DISEASE-FREE STATUS OF AQUATIC ANIMALS
Viral haemorrhagic septicaemia (VHS) |
Chapter 1 |
Infectious haematopoietic necrosis (IHN) |
Chapter 1 |
Infection with HPR-deleted infectious salmon anaemia virus |
Chapter 2 |
Infection with Marteilia refringens |
Chapter 3 |
Infection with Bonamia exitiosa |
Chapter 4 |
Infection with Bonamia ostreae |
Chapter 5 |
Infection with white spot syndrome virus (WSSV) |
Chapter 6 |
CHAPTER 1
Eradication, disease-free status and diagnostic methods for viral haemorrhagic septicaemia (VHS) and infectious hematopoietic necrosis (IHN)
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from VHS or free from IHN in Member States, zones and compartments of unknown health status
Type of establishment |
Number of health visits per year to each establishment |
Number of samplings per year in each establishment |
Number of fish in the sample(1) |
|||
Number of growing fish |
Number of broodstock fish(2) |
|||||
|
2 |
2 |
50 (first visit) 75 (second visit) |
30 (first or second visit) |
||
|
2 |
1 |
0 |
75 (first or second visit) |
||
|
2 |
2 |
75 (first AND second visit) |
0 |
||
Maximum number of fish per pool: 10 |
Type of establishment |
Number of health visits per year to each establishment |
Number of samplings per year in each establishment |
Number of fish in the sample(3) |
|||
Number of growing fish |
Number of broodstock fish(4) |
|||||
First 2 years |
||||||
|
2 |
1 |
30 (second visit) |
0 |
||
|
2 |
1 |
0 |
30 (first or second visit) |
||
|
2 |
1 |
30 (first or second visit) |
0 |
||
Last 2 years |
||||||
|
2 |
2 |
30 (first visit) |
30 (second visit) |
||
|
2 |
2 |
|
30 (first AND second visit) |
||
|
2 |
2 |
30 (first AND second visit) |
|
||
Maximum number of fish per pool: 10 |
Section 3
Granting of the status free from VHS or free from IHN in Member States, zones and compartments known to be infected with either VHS or IHN
Section 4
Maintenance of status free from VHS and status free from IHN
Risk level(5) |
Number of health visits per year to each establishment |
Number of fish in the sample(6),(7) |
High |
1 every year |
30 |
Medium |
1 every 2 years |
30 |
Low |
1 every 3 years |
30 |
Maximum number of fish per pool: 10 |
Section 5
Diagnostic and sampling methods
CHAPTER 2
Eradication, disease-free status and diagnostic methods for infection with HPR-deleted infectious salmon anaemia virus (HPR-deleted ISAV)
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from infection with HPR-deleted ISAV in Member States, zones and compartments of unknown health status
Year of surveillance |
Number of health visits per year to each establishment |
Number of laboratory examinations per year(8) |
Number of fish in the sample |
Year 1 |
6 |
2 |
75 |
Year 2 |
6 |
2 |
75 |
Maximum number of fish per pool: 5. |
Section 3
Granting of the status free from infection with HPR-deleted ISAV in Member States, zones and compartments known to be infected with HPR-deleted ISAV
Section 4
Maintenance of status free from infection with HPR-deleted ISAV
Risk level(10) |
Number of health visits per year |
Number of laboratory examinations per year(11),(12) |
Number of fish in the sample |
High |
2 |
2 |
30 |
Medium |
1 |
1 |
30 |
Low |
1 every 2 years |
1 every 2 years |
30 |
Maximum number of fish per pool: 5 |
Section 5
Diagnostic and sampling methods
CHAPTER 3
Eradication, disease-free status and diagnostic methods for infection with
Marteilia refringens
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from infection with
Marteilia Refringens
in Member States, zones and compartments of unknown health status
Year of surveillance |
Number of health visits per year to each establishment/group of establishments |
Number of laboratory examinations per year |
Number of molluscs in the sample |
Year 1 |
1 |
1 |
150 |
Year 2 |
1 |
1 |
150 |
Year 3 |
1 |
1 |
150 |
Section 3
Granting of the status free from infection with
Marteilia refringens
in Member States, zones and compartments known to be infected with
Marteilia refringens
Section 4
Maintenance of status free from infection with
Marteilia refringens
Risk level(13) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 3 years |
1 every 3 years |
150 |
Section 5
Diagnostic and sampling methods
CHAPTER 4
Eradication, disease-free status and diagnostic methods for infection with
Bonamia exitiosa
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from infection with
Bonamia exitiosa
in Member States, zones and compartments of unknown health status
Year of surveillance |
Number of health visits per year to each establishment or group of establishments |
Number of laboratory examinations per year |
Number of molluscs in the sample |
Year 1 |
2 |
2 |
150 |
Year 2 |
2 |
2 |
150 |
Year 3 |
2 |
2 |
150 |
Section 3
Granting of the status free from infection with
Bonamia exitiosa
in Member States, zones and compartments known to be infected with
Bonamia exitiosa
Section 4
Maintenance of status free from infection with
Bonamia exitiosa
Risk level(14) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 3 years |
1 every 3 years |
150 |
Section 5
Diagnostic and sampling methods
CHAPTER 5
Eradication, disease-free status and diagnostic methods for infection with
Bonamia ostreae
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from infection with
Bonamia ostreae
in Member States, zones and compartments of unknown health status
Section 3
Granting of the status free from infection with
Bonamia ostreae
in Member States, zones and compartments known to be infected with
Bonamia ostreae
Year of surveillance |
Number of health visits per year to each establishment or group of establishments |
Number of laboratory examinations per year |
Number of molluscs in the sample |
Year 1 |
1 |
1 |
150 |
Year 2 |
1 |
1 |
150 |
Year 3 |
1 |
1 |
150 |
Section 4
Maintenance of status free from infection with
Bonamia ostreae
Risk level(15) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 3 years |
1 every 3 years |
150 |
Section 5
Diagnostic and sampling methods
CHAPTER 6
Eradication, disease-free status and diagnostic methods for infection with white spot syndrome virus (WSSV)
Section 1
General requirements for health visits and sampling
Section 2
Granting of the status free from infection with
WSSV
in Member States, zones and compartments of unknown health status
Section 3
Granting of the status free from infection with WSSV in Member States, zones and compartments known to be infected with WSSV
Year of surveillance |
Number of health visits per year to each establishment or group of establishments |
Number of laboratory examinations per year |
Number of crustaceans in the sample |
Year 1 |
1 |
1 |
150 |
Year 2 |
1 |
1 |
150 |
Section 4
Maintenance of status free from infection with
WSSV
Risk level(16) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of crustaceans in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 2 years |
1 every 4 years |
150 |
Section 5
Diagnostic and sampling methods
PART III
REQUIREMENTS FOR DEMONSTRATING THE IMPLEMENTATION OF SURVEILLANCE PROGRAMMES FOR CATEGORY C DISEASES AND FOR RESTARTING THOSE PROGRAMMES AFTER A DISEASE OUTBREAK
Viral haemorrhagic septicaemia (VHS) |
Chapter 1 |
Infectious haematopoietic necrosis (IHN) |
Chapter 1 |
Infection with HPR-deleted infectious salmon anaemia virus |
Chapter 2 |
Infection with Marteilia refringens |
Chapter 3 |
Infection with Bonamia exitiosa |
Chapter 4 |
Infection with Bonamia ostreae |
Chapter 5 |
Infection with white spot syndrome virus (WSSV) |
Chapter 6 |
CHAPTER 1
Requirements for establishments to demonstrate the implementation of a surveillance programme for VHS or IHN and requirements to re-start that programme following a disease outbreak
Section 1
General requirements for health visits and sampling for VHS and IHN
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Section 3
Requirements to re-start a surveillance programme after a disease outbreak
Risk level(17) |
Number of health visits per year to each establishment |
Number of fish in the sample(18) |
High |
1 every year |
30 |
Medium |
1 every 2 years |
30 |
Low |
1 every 3 years |
30 |
CHAPTER 2
Requirements for establishments to demonstrate the implementation of a surveillance programme for HPR-deleted ISAV and to re-start that programme after a disease outbreak
Section 1
General requirements for health visits and sampling for infection with HPR-deleted ISAV
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Risk level(19) |
Number of health visits per year to each establishment |
Number of laboratory examinations per year |
Number of fish in the sample |
High |
2 |
2(20) |
30 |
Medium |
1 |
1(21) |
30 |
Low |
1 every 2 years |
1 every two years |
30 |
Maximum number of fish per pool: 5 |
Section 3
Requirements to re-start a surveillance programme after a disease outbreak
CHAPTER 3
Requirements for establishments to demonstrate the implementation of a surveillance programme for infection with
Marteilia refringens
and requirements to re-start that programme following a disease outbreak
Section 1
General requirements for health visits and sampling for infection with
Marteilia refringens
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Risk level(22) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 2 years |
1 every 4 years |
150 |
Section 3
Requirements to re-start a surveillance programme after a disease outbreak
CHAPTER 4
Requirements for establishments to demonstrate the implementation of a surveillance programme for infection with
Bonamia exitiosa
and to re-start that programme following a disease outbreak
Section 1
General requirements for health visits and sampling for infection with
Bonamia exitiosa
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Risk level(23) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 2 years |
1 every 4 years |
150 |
Section 3
Requirements to re-start a surveillance programme after a disease outbreak
CHAPTER 5
Requirements for establishments to demonstrate the implementation of a surveillance programme for infection with
Bonamia ostreae
and to re-start that programme following a disease outbreak
Section 1
General requirements for health visits and sampling for infection with
Bonamia ostreae
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Risk level(24) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of molluscs in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 2 years |
1 every 4 years |
150 |
Section 3
Requirements to re-start a surveillance programme after a disease outbreak
CHAPTER 6
Requirements for establishments to demonstrate the implementation of a surveillance programme for infection with WSSV and to re-start that programme following a disease outbreak
Section 1
General requirements for health visits and sampling for infection with infection with WSSV
Section 2
Specific requirements to demonstrate the implementation of a surveillance programme
Risk level(25) |
Number of health visits to each establishment/group of establishments |
Number of laboratory examinations |
Number of crustaceans in the sample |
High |
1 every year |
1 every 2 years |
150 |
Medium |
1 every 2 years |
1 every 2 years |
150 |
Low |
1 every 2 years |
1 every 4 years |
150 |